Cargando…
Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data
Dexamethasone, a synthetic glucocorticoid, has previously shown mortality benefit in severe coronavirus disease 2019 (COVID-19) in a randomized controlled trial. As the illness is considered to reflect a hyperinflammatory state, this therapeutic effectiveness is presumably ascribed to broad anti-inf...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054526/ https://www.ncbi.nlm.nih.gov/pubmed/33887367 http://dx.doi.org/10.1016/j.gene.2021.145665 |